Naturally Splendid Enterprises Ltd. (TSXV:NSP) (OTCQB:NSPDF) (Frankfurt:50N) (“Naturally Splendid” or “NSE” or “The Company”) is pleased to announce the appointment of Mr. Bob Mehr, B.Sc. (Pharm) FIACP to the Company’s Advisory Board. Mr. Mehr will focus on NATERA FX™, with special attention directed to the roll out of NATERA FX™ into naturopathic clinics, functional medicine practices and pharmacies in Canada initially, with a view to expanding into the United States, Australia, Europe and Asia.
Mr. Mehr opened his first Integrative Pharmacy in Shawnigan Lake on Vancouver Island in British Columbia in 1999 and has established a total of 15 Pure Integrative Pharmacies in the Greater Vancouver area. Bob is President and founder of Pure Integrative Pharmacy, a position he has held for over 18 years, guiding the Company to being recognized as a clear leader and innovator in its field.
Mr. Mehr’s vision combines a holistic and integrative health model with traditional pharmacy services. NATERA FX™ is the natural progression of Bob’s philosophy. Bob has developed into a business innovator and industry leader. Bob’s vision, passion and expertise will be of great value to expanding the NATERA FX™ reach though naturopathic clinics, functional medicine practices and pharmacies.
Mr. Mehr states, “As a Compounding Pharmacist, I am very discriminate in regard to individual ingredients within the formulations of the products we recommend. In this respect, the NATERA FX™ line of practitioner formulated products exceeds my self imposed, high-standards. I look forward to assisting NATERA FX™ in becoming a success in Canada and expanding to professional clinics throughout the world.”
Mr. Mehr is a leader in integrative healthcare. He has specialized training from the PCAA (the Professional Compounding Center of America) and his devotion to the profession has earned him recognition such as Top Compounding Pharmacist as well as several other awards and recognitions most notably, Outstanding Pharmacy Owner at the Commitment to Care and Service Awards. Bob is also a proud supporter of Inspire Health Integrative Cancer Care located in Vancouver. By dedicating his time as a volunteer clinical pharmacist, he is able to assist Inspire Health by meeting with cancer patients to review their medications and supplements.
Naturally Splendid CEO Mr. Doug Mason states, “We are privileged with the addition of Mr. Mehr’s expertise in pharmaceuticals, formulated products, and business innovation to the NSE team. Mr. Mehr will be invaluable as we continue to penetrate the professional Health clinics sector with the practitioner formulated NATERA FX™ brand. Having our products represented at these professional clinics adds instant brand recognition, credibility, and quality assurance, as they are renowned for their high-standards in product procurement.”
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp cannabinoid compounds in a broad spectrum of applications.
For more information e-mail firstname.lastname@example.org or call Investor Relations at 604-673-9573
On Behalf of the Board of Directors
Mr. Douglas Mason
Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.